Digital Psychotherapeutics Market Report 2026

Digital Psychotherapeutics Market Overview

• Digital Psychotherapeutics market size has reached to $2.4 billion in 2025 • Expected to grow to $8.23 billion in 2030 at a compound annual growth rate (CAGR) of 26.9% • Growth Driver: Digital Psychotherapeutics Market Set To Grow Amid Increasing Disorder Incidence • Market Trend: Innovative Six-Week Program Demonstrates Sustained Symptom Improvement For Depression • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Digital Psychotherapeutics Market?

Digital psychotherapeutics refers to online or digital platforms and tools used for delivering psychotherapeutic interventions and treatments that are accessed through mobile apps, web-based platforms, or virtual reality applications. The main types of digital psychotherapeutics are mobile apps, online platforms, virtual reality, and wearable devices. Mobile apps are software applications designed to run on smartphones or tablets, offering various functionalities and services to users. The various indications include phobias and anxiety disorders, psychotic disorders, and others that are used by various business models such as direct-to-patients or consumers, and business-to-business (b2b). These are also used in various applications such as prevention, management, and treatment and also by various end users such as healthcare providers, and payers.

What Is The Digital Psychotherapeutics Market Growth Forecast?

The digital psychotherapeutics market size is expected to see exponential growth in the next few years. It will grow to $8.23 billion in 2030 at a compound annual growth rate (CAGR) of 26.9%. The growth in the forecast period can be attributed to ai-assisted therapy platforms, employer mental health programs, clinical validation of digital therapeutics, vr-based exposure therapy growth, insurance reimbursement expansion. Major trends in the forecast period include increasing use of app-based mental health therapies, growing adoption of digital cbt platforms, expansion of remote psychological care models, rising demand for anxiety and stress management tools, integration of wearables for mental health monitoring.

Global Digital Psychotherapeutics Market Segmentation

1) By Type: Mobile Apps, Online Platforms, Virtual Reality, Wearable Devices 2) By Indication: Phobias And Anxiety Disorders, Psychotic Disorders, Other Indications 3) By Business Model: Direct-To-Patients Or Consumers, Business-To-Business (B2B) 4) By Application: Prevention, Management, Treatment 5) By End User: Healthcare Providers, Payers Subsegments: 1) By Mobile Apps: Mental Health Apps, Cognitive Behavioral Therapy (CBT) Apps, Meditation And Mindfulness Apps, Mood Tracking Apps, Sleep Management Apps 2) By Online Platforms: Telehealth Platforms, Online Therapy Services, Web-Based Mental Health Counseling, Virtual Support Groups, Digital CBT Platforms 3) By Virtual Reality (VR): VR-Based Exposure Therapy, VR-Assisted CBT, Immersive Meditation VR, VR For Stress Management, VR For PTSD And Anxiety Treatment 4) By Wearable Devices: Biofeedback Wearables, Stress And Anxiety Monitoring Wearables, Sleep-Tracking Wearables, Heart Rate Variability Wearables, Wearables For Mood Tracking And Emotional Regulation

What Is The Driver Of The Digital Psychotherapeutics Market?

The increasing incidence of mental health disorders is expected to propel the growth of the digital psychotherapeutics market going forward. Mental health disorders refer to a range of conditions that affect a person's thoughts, emotions, and behavior, leading to distress and impaired functioning in daily life. The surge in mental health disorders can be attributed to increased stress levels, societal pressures, and trauma, which fuel demand for therapeutic interventions. Digital psychotherapy provides convenience by offering flexible scheduling options and eliminating the need for travel to therapy appointments. For instance, in November 2023, according to National Health Service (NHS) Digital, a UK government agency responsible for collecting and publishing national health and care statistics, around 1 in 5 children and young people aged 8 to 25 years were identified as having a probable mental disorder in 2023. The reported prevalence was 20.3% among those aged 8 to 16, 23.3% among individuals aged 17 to 19, and 21.7% among young adults aged 20 to 25. Therefore, the rise in the incidence of mental health disorders is driving the growth of the digital psychotherapeutics industry.

Key Players In The Global Digital Psychotherapeutics Market

Major companies operating in the digital psychotherapeutics market are AbleTo Inc., BetterHelp Inc., Ginger.io Inc., Meru Health Inc., Novartis International AG, Pear Therapeutics Inc., SilverCloud Health Limited, Spring Health Inc., Starling Minds Inc., SwissDT AG, Talkspace Inc., Woebot Health Inc., CBT Nuggets LLC, Quartet Health Inc., Neurotrack Technologies Inc., Limbix Health Inc., Happify Health LLC, Mindstrong Health Inc., Minddistrict B.V., Ieso Digital Health, Eleos Health, MDLIVE, Lyra Health

Global Digital Psychotherapeutics Market Trends and Insights

Major companies operating in the prescription digital therapeutics market are focusing on incorporating software-as-a-medical-device (SaMD) such as digital psychotherapeutic applications, to enhance treatment accessibility, patient engagement, and clinical effectiveness. Digital psychotherapeutic applications are software-based medical tools that deliver structured, evidence-based therapeutic interventions through mobile platforms, enabling capabilities such as guided cognitive-emotional training, remote therapy delivery, and real-time patient support. For instance, in April 2024, Otsuka Pharmaceutical Co., Ltd., a Japan-based global healthcare company, received US Food and Drug Administration (FDA) approval for Rejoyn, a prescription digital therapeutic designed to support adults with major depressive disorder (MDD) when used alongside antidepressant medication, featuring a six-week app-based program integrating cognitive-emotional training and brief therapeutic lessons, smartphone deployment on both iOS and Android, and clinical validation from a large remote randomized trial. Rejoyn improves treatment outcomes, adherence, and access to structured psychotherapy.

What Are Latest Mergers And Acquisitions In The Digital Psychotherapeutics Market?

In July 2023, Big Health Inc., a US-based provider of non-drug digital treatments for conditions such as insomnia and anxiety, acquired Limbix for an undisclosed amount. With this acquisition, Big Health gains access to Limbix’s adolescent-focused digital therapeutic pipeline, including the evidence-backed SparkRx program for teen depression, thereby enhancing its capabilities in youth mental health while improving its overall scale, reach, and treatment portfolio. Limbix Inc. is a US-based developer of digital therapeutics for teens and young adults with symptoms of depression, known for its self-guided cognitive behavioral therapy (CBT)-based mobile intervention and strong clinical research foundation.

Regional Outlook

North America was the largest region in the digital psychotherapeutics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digital Psychotherapeutics Market?

The digital psychotherapeutics market consists of revenues earned by entities by providing services such as virtual counseling sessions, online therapy, and teletherapy services that assist in delivering mental health support and interventions remotely. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital psychotherapeutics market also includes sales of digital therapy devices, remote monitoring tools, interactive online programs, and computer-based cognitive behavioral therapy (CBT) platforms that help in mental health management. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Psychotherapeutics Market Report 2026?

The digital psychotherapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital psychotherapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.